comparemela.com

Summit Annual Meeting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ocular Therapeutix™ To Present 12-Month Top-Line Data from U S -Based Phase 1 Clinical Trial of OTX-TKI in Wet Age-Related Macular Degeneration at the 2023 Clinical Trials at the Summit Annual Meeting

BEDFORD, Mass., June 05, 2023 Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and. | June 5, 2023

Park cityUnited statesArshadm khananiJeffrey heierPeterk kaiserReenie mccarthyAlexander hardyChris brinzeyJoel naorMohamed geneadRabia gurses ozdenDonald notmanAntony mattessichVictor perlrothExchange commissionGlobenewswire inc

vimarsana © 2020. All Rights Reserved.